Literature DB >> 23001813

Effects of erythropoietin on blood-brain barrier tight junctions in ischemia-reperfusion rats.

Kun Liu1, Tao Sun, Ping Wang, Yun-hui Liu, Li-wei Zhang, Yi-xue Xue.   

Abstract

Administration of recombinant human erythropoietin (rhEPO) protects neurons from injury after brain ischemia-reperfusion (I/R), which is in part mediated by ameliorating the blood-brain barrier (BBB) leakage. But the mechanism of rhEPO's protective effects on BBB remains unclear. This study aims to investigate the effects of rhEPO on BBB integrity and the expressions of tight junctions (TJs) associated proteins of zonula occluden-1 (ZO-1), occludin, and claudin-5 in cerebral I/R rats. These rats underwent 2 h of ischemia and then were reperfused for up to 3 and 72 h. Animals were randomly divided into five groups: sham-operated group, I/R 3 h and I/R 72 h group (2 ml saline was injected intraperitoneally just before the onset of ischemia), rhEPO +I/R 3 h, and rhEPO +I/R 72 h group (5,000 U/kg rhEPO diluted in 2 ml saline solution was injected intraperitoneally just before the onset of ischemia). We verified that rhEPO could decrease the BBB leakage induced by I/R injury detected by Evans blue extravasation. 2, 3, 5-Triphenyltetrazolium chloride staining results showed that rhEPO decreased infarct volume after cerebral I/R. TJ integrity was partly restored by rhEPO observed by transmission electron microscopy. The mRNA and protein expression levels of ZO-1, occludin, and claudin-5 were significantly increased compared with I/R groups at the same reperfusion time point by reverse transcriptase-polymerase chain reaction and Western blot assays. The treatment of rhEPO induced the redistribution of ZO-1, occludin, and claudin-5 in cerebral microvessels observed by immunohistochemical staining. Compared with I/R groups, the mRNA level of tumor necrosis factor-alpha (TNF-α) in cerebral microvessels decreased markedly after rhEPO treatment, accompanied with reduced TNF-α protein level and nuclear factor-кB (NF-кB) p65 activation detected by enzyme-linked immunosorbent assay. These results suggested that the protective mechanism of rhEPO on BBB after cerebral I/R injury was associated with the upregulation of TJ-associated proteins. The downregulated TNF-α levels and NF-кB activation induced by rhEPO might be involved in this process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001813     DOI: 10.1007/s12031-012-9883-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  37 in total

1.  Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion.

Authors:  A Shimakura; Y Kamanaka; Y Ikeda; K Kondo; Y Suzuki; K Umemura
Journal:  Brain Res       Date:  2000-03-06       Impact factor: 3.252

Review 2.  Erythropoietin after a century of research: younger than ever.

Authors:  Wolfgang Jelkmann
Journal:  Eur J Haematol       Date:  2007-01-23       Impact factor: 2.997

3.  Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture.

Authors:  A Nagai; E Nakagawa; H B Choi; K Hatori; S Kobayashi; S U Kim
Journal:  J Neuropathol Exp Neurol       Date:  2001-04       Impact factor: 3.685

4.  TNF-alpha induced NFκB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells.

Authors:  Muhammad Aslam; Nafees Ahmad; Rajneesh Srivastava; Bernhard Hemmer
Journal:  Cytokine       Date:  2011-12-03       Impact factor: 3.861

5.  Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia.

Authors:  Z G Huang; D Xue; E Preston; H Karbalai; A M Buchan
Journal:  Can J Neurol Sci       Date:  1999-11       Impact factor: 2.104

6.  Erythropoietin downregulates bax and DP5 proapoptotic gene expression in neonatal hypoxic-ischemic brain injury.

Authors:  Abdullah Kumral; Sermin Genc; Erdener Ozer; Osman Yilmaz; Necati Gokmen; Tolga F Koroglu; Nuray Duman; Kursad Genc; Hasan Ozkan
Journal:  Biol Neonate       Date:  2005-11-24

7.  Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling.

Authors:  Gerty Schreibelt; Gijs Kooij; Arie Reijerkerk; Ruben van Doorn; Sonja I Gringhuis; Susanne van der Pol; Babette B Weksler; Ignacio A Romero; Pierre-Olivier Couraud; Jörg Piontek; Ingolf E Blasig; Christine D Dijkstra; Eric Ronken; Helga E de Vries
Journal:  FASEB J       Date:  2007-06-22       Impact factor: 5.191

8.  Erythropoietin attenuates intracerebral hemorrhage by diminishing matrix metalloproteinases and maintaining blood-brain barrier integrity in mice.

Authors:  Y Li; M E Ogle; G C Wallace; Z Y Lu; S P Yu; L Wei
Journal:  Acta Neurochir Suppl       Date:  2008

Review 9.  Ischemia-mediated neuronal injury.

Authors:  K A Hossmann
Journal:  Resuscitation       Date:  1993-12       Impact factor: 5.262

10.  Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability.

Authors:  Ofelia María Martínez-Estrada; Elisabeth Rodríguez-Millán; Esther González-De Vicente; Manuel Reina; Senén Vilaró; Myriam Fabre
Journal:  Eur J Neurosci       Date:  2003-11       Impact factor: 3.386

View more
  11 in total

1.  CT Permeability Imaging Predicts Clinical Outcomes in Acute Ischemic Stroke Patients Treated with Intra-arterial Thrombolytic Therapy.

Authors:  Nan Liu; Hui Chen; Bing Wu; Ying Li; Max Wintermark; Alan Jackson; Jun Hu; Yongwei Zhang; Zihua Su; Guangming Zhu; Weiwei Zhang
Journal:  Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.590

2.  Differential short-term regional effects of early high dose erythropoietin on white matter in preterm lambs after mechanical ventilation.

Authors:  Samantha K Barton; Annie R A McDougall; Jacqueline M Melville; Timothy J M Moss; Valerie A Zahra; Tammy Lim; Kelly J Crossley; Graeme R Polglase; Mary Tolcos
Journal:  J Physiol       Date:  2015-10-08       Impact factor: 5.182

3.  Erythropoietin protects against hemorrhagic blood-brain barrier disruption through the effects of aquaporin-4.

Authors:  Heling Chu; Hongyan Ding; Yuping Tang; Qiang Dong
Journal:  Lab Invest       Date:  2014-06-30       Impact factor: 5.662

4.  Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke.

Authors:  Stefan Reischl; Lexiao Li; Gail Walkinshaw; Lee A Flippin; Hugo H Marti; Reiner Kunze
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

5.  Ischemic preconditioning protects against spinal cord ischemia-reperfusion injury in rabbits by attenuating blood spinal cord barrier disruption.

Authors:  Bo Fang; Xiao-Man Li; Xi-Jia Sun; Na-Ren Bao; Xiao-Yan Ren; Huang-Wei Lv; Hong Ma
Journal:  Int J Mol Sci       Date:  2013-05-17       Impact factor: 5.923

6.  Diosmin alleviates retinal edema by protecting the blood-retinal barrier and reducing retinal vascular permeability during ischemia/reperfusion injury.

Authors:  Nianting Tong; Zhenzhen Zhang; Wei Zhang; Yating Qiu; Yuanyuan Gong; Lili Yin; Qinghua Qiu; Xingwei Wu
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

7.  Human recombinant erythropoietin improves motor function in rats with spinal cord compression-induced cervical myelopathy.

Authors:  Takahiro Tanaka; Hidetoshi Murata; Ryohei Miyazaki; Tetsuya Yoshizumi; Mitsuru Sato; Makoto Ohtake; Kensuke Tateishi; Phyo Kim; Tetsuya Yamamoto
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

Review 8.  Effects and Mechanisms of Five Psoralea Prenylflavonoids on Aging-Related Diseases.

Authors:  Yi-Ting Zhou; Lin Zhu; Yunyun Yuan; Shuang Ling; Jin-Wen Xu
Journal:  Oxid Med Cell Longev       Date:  2020-06-17       Impact factor: 6.543

9.  Long non-coding RNA MIAT regulates blood tumor barrier permeability by functioning as a competing endogenous RNA.

Authors:  Jiayuan He; Yixue Xue; Qingyuan Wang; Xinxin Zhou; Libo Liu; Tianyuan Zhang; Chao Shang; Jun Ma; Teng Ma
Journal:  Cell Death Dis       Date:  2020-10-30       Impact factor: 8.469

Review 10.  Transient Receptor Potential Vanilloid in the Brain Gliovascular Unit: Prospective Targets in Therapy.

Authors:  Huilong Luo; Xavier Declèves; Salvatore Cisternino
Journal:  Pharmaceutics       Date:  2021-03-04       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.